At the news
? NEUTRALIMPACT 4/10 DEFA14A filed Apr 8, 2026 at 16:33 ET
Sotera Health Co filed a definitive proxy statement for its 2026 Annual Meeting, proposing the election of four Class III directors, approval of executive compensation, and ratification of its independent auditor. This filing follows a recent 8-K report detailing the resignation of director Constantine Mihas and the appointment of Kenneth Krause, suggesting board changes are materializing near the shareholder vote.
- Filing is a definitive proxy statement (DEFA14A) for the 2026 Annual Meeting of Stockholders.
- Proposals include electing four Class III directors (Sean L. Cunningham, Richard G. Kyle, Vincent K. Petrella, Christopher A. Simon), approving executive compensation, and ratifying Ernst & Young as auditor.
- Recent 8-K filing (Items 5.02) reported the resignation of director Constantine Mihas and the appointment of Kenneth Krause.
- The proxy filing context indicates board/executive changes are occurring near the proxy materials, suggesting the vote may be materializing from a prior situation.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access